Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122426) titled 'Construction and Empirical Study of a Comprehensive Prevention and Control Model Involving Clinical Pharmacist Intervention for Chemotherapy-Induced Myelosuppression' on April 14.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Yuebei People's Hospital
Condition:
Chemotherapy-induced myelosuppression
Intervention:
Control group:Treated in accordance with normal medical procedures
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-15
Target Sample Size: Control group:100;Intervention group:100;
Countries of Recruitment:
China
To know more, vis...